Jena Acquisition Corporation II NYSE Non-Compliance
Analysis based on 7 articles · First reported Apr 03, 2026 · Last updated Apr 03, 2026
The market impact on Jena Acquisition Corporation II is negative due to the non-compliance notice, creating uncertainty about its continued listing on the New York Stock Exchange. While the notice has no immediate impact on its securities, failure to regain compliance could lead to delisting, affecting investor confidence and stock value.
Jena Acquisition Corporation II received a written notice from NYSE Regulation on April 1, 2026, indicating non-compliance with Section 802.01B of the NYSE Listed Company Manual, which requires a minimum of 300 public stockholders. Jena Acquisition Corporation II plans to submit a business plan within 18 months to regain compliance, which will involve completing a de-SPAC transaction. The notice does not immediately affect Jena Acquisition Corporation II's securities, and they will continue to be listed and traded on the New York Stock Exchange during the cure period, provided the plan is approved.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard